High prevalence of chronic obstructive pulmonary disease among veterans in the Urban midwest

Military Medicine

Volumn 176, Issue 5, 2011, Pages 552-560

  Murphy, Daniel E ^a,b   Chaudhry, Zeshan ^a   Almoosa, Khalid F ^c   Panos, Ralph J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; MIDDLE AGED; OCCUPATION; PATHOPHYSIOLOGY; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; UNITED STATES; VETERAN;

BRONCHODILATOR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDWESTERN UNITED STATES; OCCUPATIONS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; RISK FACTORS; VETERANS;

EID: 79960931679     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED-D-10-00377     Document Type: Article

References (44)

1. Pauwels RA, Buist AS, Calverley PM, GOLD Scientific Committee: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-76.
2. National Heart, Lung and Blood Institute: Morbidity and Mortality: Chartbook on Cardiovascular, Lung and Blood diseases. Bethesda, MD, U.S. Department of health and human services, public health service, NIH, 1998.
3. Mannino DM, Gagnon RC, Petty TL, et al: Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1984-1994. Arch Intern Med 2000; 160: 1683-9.
4. Hoyert DL, Kocha KD, Murphy SL: Death; Final Data for the 1997 National Vital Statistics Reports 1999. U.S. Dept. of Health and Human Services Publication (PHS) 99-1120. Hyattsville, MD, National Center for Health Statistics, 1999.
5. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-504.
6. Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3 (11): e442.
7. McDonald M, Hertz RP: Utilization of Veterans Affairs Medical Care Services by United States Veterans, Population Studies Outcomes Research, Pfizer Global Pharmaceuticals. Available at http://www.hawaii.edu/hivandaids/Utilization%20of%20Veterans%20Affairs%20Medical%20Care%20Services%20by%20US%20Veterans.pdf; accessed Nov 2010).
8. Lundback B, Nystrom L, Rosenhall L, et al: Obstructive lung disease in northern Sweden: respiratory symptoms assessed in postal survey. Eur Respir J 1991; 4: 257-66.
9. Rennard S, Decramer M, Calverley PM, et al: Impact of COPD in North America and Europe in 2000: subjects perspective of confronting COPD international survey. Eur Respir J 2002; 20: 799-805.
10. Takahashi T, Ichinose M, Inoue H, et al: Underdiagnosis and undertreatment of COPD in primary care settings. Respirology 2003; 8: 504-8.
11. Damarla M, Celli BR, Mullerova HX, et al: Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care 2006; 51 (10): 1120-4.
12. Fukuchi Y, Nishimura M, Ichinose M, et al: COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004; 9: 458-65.
13. Dickinson JA, Meaker M, Searle M: Screening older patients for obstructive lung disease in a semi-rural practice. Thorax 1999; 54: 501-5.
14. Pena VS, Miravitlles M, Gabriel R, et al: Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multi-center epidemiological study. Chest 2000; 118: 981-9.
15. Hnizdo E, Sullivan P, Bang KM, et al: Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the third National Health and Nutrition Examination Survey. Am J Epidemiol 2002; 156: 738-46.
16. Bray RM, Marsden ME, Guess LL, et al: Prevalence, trends, and correlates of alcohol use, nonmedical drug use, and tobacco use among U.S. military personnel. Mil Med 1989; 154: 1-11.
17. Bray RM, Marsden ME, Peterson MR: Standarized comparisons of the use of alcohol, drugs, and cigarettes among military personnel and civilians. Am J Public Health 1991; 81: 865-9.
18. Klevens RM, Giovino GA, Peddicord JP, et al: The association between veteran status and cigarette-smoking behaviors. Am J Prev Med 1995; 11: 245-50.
19. Murtagh E, Heaney L, Gingles J, et al: The prevalence of obstructive lung disease in a general population sample: the NICECOPD Study. Eur J Epidem 2005; 20: 443-53.
20. Centers for Disease Control and Prevention (CDC): National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey questionnaire. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, COPD Surveillance-United States, 1971-2000. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5106a1.htm; accessed Nov 2010.
21. American Thoracic Society: Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-36.
22. Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-87.
23. Creative Research Systems. Sample size calculator. www.surveysystem.com/sscale.htm; accessed November 2010.
24. Graphpad Software: Quick Calcs online calculators for scientists. Available at http://www.graphpad.com/quickcalcs/chisquared1.cfm; accessed November 2010.
25. Buist AS, McBurnie MA, Vollmer WM, et al: International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-50.
26. Menezes AM, Perez-Padilla R, Jardim JR, et al: Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366 (9500): 1832-4.
27. Methvin JN, Mannino DM, Casey BR: COPD prevalence in southeastern Kentucky. Chest 2009; 135: 102-7.
28. Perez-Padilla R, Hallal PC, Vazquez-Garcia JC, et al: Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007; 4: 113-20.
29. Bednarek M, Maciejewski J, Wozniak M, et al: Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008; 63: 402-7.
30. Johannessen A, Omenaas ER, Bakke PS, et al: Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005; 60: 842-7.
31. Petty TL: Scope of the COPD problem in North America. Chest 2000; 117: 326S-331S.
32. Lundback B, Lindberg A, Lindstroem M, et al: Not 15 but 50% of smokers develop COPD: report from the obstructive lung disease in Northern Sweden Studies. Respir Med 2003; 97: 115-22.
33. deTorres JP, Campo A, Casanova C, et al: Gender and chronic obstructive pulmonary disease in high-risk smokers. Respiration 2006; 73: 306-10.
34. Mohangoo AD, van der Linden MW, Schellevis FG, et al: Prevalence estimates of asthma or COPD from a health interview survey and from general practitioner registration: what's the difference? Eur J Public Health 2005; 16: 101-5.
35. Celli BR, Halbert RJ, Isonaka S, et al: Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22: 268-73.
36. Shirtcliffe P, Wheatherall M, Marsh S, et al: COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007; 30 (2): 232-9.
37. Swanney MP, Ruppel G, Enright PL, et al: Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-51.
38. Vaz Fragoso CA, Concato J, McAvay, et al: Defining chronic obstructive pulmonary disease in older persons. Respir Med 2009; 103: 1468-76.
39. Hardie JA, Buist AS, Vollmer WM, et al: Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20: 1117-22.
40. Roberts SD, Farber MO, Knox KS, et al: FEV1/FVC ratio of 70% misclassify es patients with obstruction at the extremes of age. Chest 2006; 130: 200-6.
41. Cerveri I, Corsico AG, Accordini S, et al: Underestimation of airflow obstruction among young adults using FEV1/FVC<70% as a fixed cutoff: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008; 63: 1040-50.
42. Mannino DM, Sonia Buist A, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007; 62: 237-41.
43. Johannessen A, Lehmann S, Omenaas ER, et al: Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006; 173: 1316-25.
44. Pellegrino R, Viegi G, Brusasco V, et al: Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-68.